Increased levels of reactive oxygen and nitrogen species -as seen in response to exercise -challenges the cellular integrity. Important protective adaptive changes include induction of heat-shock proteins (HSPs). We hypothesized that supplementation with antioxidant vitamins C (ascorbic acid) and E (tocopherol) would attenuate the exerciseinduced increase of HSP72 in the skeletal muscle and in the circulation. Using randomization, 21 young men were allocated into three groups receiving one of following oral supplementations: RRR--tocopherol 400 IU/day + ascorbic acid (AA) 500 mg/day (CE ), RRR--tocopherol 290 IU/day + RRR--tocopherol 130 IU/day + AA 500 mg/day (CE ), or placebo (CONTROL). After 28 days of supplementation, the subjects performed 3 hours of knee-extensor exercise at 50% of the maximal power output. HSP72 mRNA and protein content was determined in muscle biopsies obtained from vastus lateralis at rest (0 h), post exercise (3 h) and after a 3-hour recovery (6 h). In addition, blood was sampled for measurements of HSP72; -tocopherol; -tocopherol; AA; and 8-isoprostaglandin-F 2 (8-PGF 2 ). Post supplementation, the groups differed with respect to plasma vitamin levels. The marker of lipid peroxidation, 8-iso-PGF 2 , increased from 0 h to 3 h in all groups, however markedly less (P<0.05) in CE . In CONTROL, skeletal muscle HSP72 mRNA content increased 2.5-fold (P<0.05) and serum HSP72 protein increased 4-fold (P<0.05) in response to exercise, while a significant increase of skeletal muscle HSP72 protein content was not observed (P=0.07). In CE , skeletal muscle HSP72 mRNA, HSP72 protein and serum HSP72 were not different from CONTROL in response to exercise. In contrast, the effect of exercise on skeletal muscle HSP72 mRNA and protein, as well as circulating HSP72 was completely blunted in CE . The results indicate thattocopherol comprises a potent inhibitor of the exercise-induced increase of HSP72 in skeletal muscle as well as in the circulation.
INTRODUCTION
Free radicals are generated continuously in the living organism as a part of normal metabolism (14) . However, the rate increases significantly in response to exercise, with the contracting skeletal muscle being a major source of both reactive oxygen species (ROS) (16; 30) and reactive nitrogen species (RNS) (5) . Though the tissue hosts a number of enzymes (e.g. superoxide dismutase, SOD, and catalase) and small molecule antioxidants (e.g. vitamins C and E) protecting partly against oxidative stress, augmented oxidative damage to lipids (2) , proteins (59) and DNA (57) has been observed after acute physical exercise. Therefore, a second line defense of the cellular integrity consisting of heat-shock proteins (HSPs) is present in all living organsims: HSPs are -when located intracellularly -chaperone-like proteins involved in folding of newly synthesized proteins, binding to denatured proteins, and translocation of proteins between subcellular compartments (22) . In addition, cell surface-bound HSPs have been shown to facilitate migration and cytotoxicity by natural killer cells (23) , while circulating HSPs promote the release of cytokines from monocytes (4) . Several studies have demonstrated that induction of HSPs prior to harmful stimuli increase the survival and preserves the function of the tissue (39; 44) .
In vitro, HSPs can be induced by ROS (45; 63) and by the mutagenic RNS compound peroxynitrite (ONOO -) (1), which is formed when superoxide (O 2 -•) reacts with nitric oxide (NO). In response to acute exercise in vivo, particularly the inducible 72-kDa member (HSP72) has been shown to increase in the contracting muscle per se (19; 43; 58) , in several other tissues (36) , as well as in the circulation (64) . Importantly, skeletal muscle HSP72 expression increases in response to a bout of concentric exercise associated with no or minimal muscle damage (19; 21; 35) . Furthermore, the exercise-induced increase of HSP72 content in rat soleus muscle is higher in untrained animals and corresponds to lower levels of glutathion reductase and catalase (59) . Therefore, an increase of skeletal muscle HSP72 content appears to be a part of the normal exercise response as well as training adaptation (41) . Accordingly, it is increasingly recognized that oxidative stress is involved in the induction of protective enzymes and HSPs in the tissue, while exogenous supplementation with antioxidants may interfere with this adaptation. For example, -tocopherol (a common isoform of vitamin E) has been shown to attenuate the increase of HSP72 in leukocytes after treadmill running (52) , while Khassaf et al showed that supplementation with ascorbic acid (vitamin C) attenuates the exercise-induced increase of skeletal muscle HSP72 but at the same time increasing baseline levels of HSP72, SOD and catalase (35) . The effect of antioxidants on circulating levels of HSP72 has not been investigated previously.
Since the combination of ascorbic acid and -tocopherol comprises a powerful antioxidant, both from an electrochemical (11) and experimental (29; 34) point of view, we hypothesized that the combined effect of the two would cause a marked attenuation of the exercise-induced HSP72 mRNA and protein expression in skeletal muscle as well as circulating HSP72. However, since -tocopherol supplementation suppresses plasma levels of -tocopherol we also examined whether a combination of ascorbic acid, -tocopherol, and -tocopherol would be a more potent inhibitor of the exercise-induced elevation of HSP72 when compared to ascorbic acid and -tocopherol alone. Of note, -tocopherol -in contrast to -tocopherol -is in vitro a potent scavenger of RNS including peroxynitrite (13; 15) and a inhibitor of cyclooxygenase activity (33) , thus possessing potential anti-inflammatory qualities.
Noteworthy, the effect of -tocopherol on the response to exercise has not been reported previously.
As a marker of lipid peroxidation, 8-iso-prostaglandin F 2 (8-iso-PGF 2 ) was employed. Of note, 8-iso-PGF 2 is a major isoform of the F 2 isoprostanes (50), which are formed by a non-enzymatic interaction between reactive oxygen species and arachidonic acid (49), thus highly suitable as a markers of lipid peroxidation.
MATERIALS AND METHODS
Participants. Twenty-one healthy men volunteered to participate in this study. All subjects were physically active non-athletes. Group characteristics are listed in Table 1 . A general medical examination in combination with blood test screening was performed before inclusion. Exclusion criteria were history of febrile illness within three weeks prior to the examination, indication of ongoing disease, recent vaccination, use of any medication, or use of supplementation with known antioxidative properties.
The purpose of the study, possible risks and discomforts were explained to the subjects before obtaining written consent. The study protocol was approved by the local Ethical Committee of Copenhagen and Frederiksberg Communities (#KF11-131/01), and was performed in accordance with the Declaration of Helsinki.
Supplementation.
A single-blind placebo-controlled design with randomization was used in order to acquire three groups of equal size (CE , CE , and CONTROL). Subjects in the CE group (n=7) received oral supplementation with ascorbic acid 500 mg/day and RRR--tocopherol 400 IU/day. This dose was based on a previous exercise experiment demonstrating attenuated oxidative stress in response to prolonged exercise (56) .
Subjects in the CE group (n=7) received oral supplementation with ascorbic acid 500 mg/day, RRR--tocopherol 292 IU/day, and RRR--tocopherol 130 IU/day. Accordingly, the supplementation employed in CE and CE contained virtually equal total vitamin E biological activity. Subjects in the CONTROL group (n=7) received placebo with similar appearance. The supplementation was ingested once a day together with breakfast. For all three groups, the length of the supplementation period prior to the final exercise experiment was 28 days. The duration of the supplementation was chosen from a previous study (47) showing that plasma tocopherol concentration reaches new steady state after at least 14 days of oral tocopherol supplementation.
Pre-experimental protocol. Three weeks prior to the exercise experiment, the individual maximal power output, P max , of the subjects was determined during two-legged dynamic knee-extensor exercise. The test was carried out using a modified ergometer described previously (3) . In brief, the subjects performed a 5 min warm-up session consisting of 60 knee-extensions with passive repositions per minute at 60 watt (W) after becoming accustomed to the exercise model. This was followed by an incremental increase of the workload by 10 W every 2 min until volitional exhaustion. The highest workload, that was maintained for at least 1 min was defined as the maximal power output, P max .
Experimental protocol. All exercise experiments were done between July and November.
On day 28 of the supplementation period the subjects reported to the laboratory at 0800 h.
Subjects had fasted overnight, and were asked to consume the supplement at 0700 h.
Furthermore, the subjects were instructed to refrain from exercise for at least 24 hours prior to the experiment. Upon arrival, subjects changed into hospital attire and rested in a Prior to the onset of exercise subjects in both groups ingested two boiled eggs to ensure maximal uptake of the supplementation ingested earlier the same morning.
The exercise bout consisted of 3 h of two-legged dynamic knee-extensor exercise at 60 extensions per minute at 50% of the individual P max .
After the exercise period, the subjects remained supine in the laboratory for a 3 h recovery period. Water was consumed ad libitum throughout the exercise and recovery period, but food was not permitted until the cessation of the recovery period.
Blood samples. Blood samples were drawn from the catheter at rest (0 h), immediately before cessation of the exercise (3 h), and at the end of the recovery period (6 h). Plasma was obtained by drawing blood into pre-cooled ethylenediaminetetraacetic acid (EDTA)-containing glass tubes, which were immediately centrifuged at 2200 g for 15 min at 4 °C.
Plasma for vitamin C analysis was stabilized with 5% metaphosphoric acid. Blood samples for measurement of epinephrine and norepinephrine concentrations were drawn into icecold glass tubes containing glutathione and ethyleneglycoltetraacetic acid (EGTA) and spun immediately. Serum for measurement of HSP72 concentration was obtained by drawing blood into glass tubes containing a clot-inducing plug. The tubes were subsequently stored on ice for 30 min before they were centrifuged at 2200 g for 15 min at 4˚C. All samples were stored at -80 °C until further analysis.
Plasma concentration of the catecholamines epinephrine and norepinephrine was measured using HPLC, while plasma glucose concentration was determined using an automatic analyzer (Cobas Fara, Roche, France), both methods described elsewhere (60).
Cortisol was measured using a RIA (#DSL-10-2000, Diagnostic Laboratories, Webster, Texas), intra-assay CV ~5%.
In addition, blood samples drawn at 0 h, 3 h and 6 h were analyzed for hemoglobin concentration and hematocrit using automated standard laboratory procedures in order to correct for possible changes in plasma volume according to the method described by Dill and Costill (18) .
Plasma ascorbic acid concentration. Ascorbic acid concentration was measured in plasma by a modified fluorometric method (17; 62) . In brief, the assay involved the enzymatic oxidation of ascorbic acid with ascorbate oxidase to dehydroascorbic acid, which subsequently reacted with 1-ortho-phenylenediamine to the fluorescent compound quinoxaline, which was quantified using an excitation wavelength of 337 nm and an emission wavelength of 430 nm. Intra-assay CV ~4%.
Plasma -tocopherol and -tocopherol concentration.
Plasma -tocopherol andtocopherol concentrations were measured using high-performance liquid chromatography (HPLC) with fluorescence detection (53) . In brief, 500 µl of plasma was extracted with 500 µl of ethanol containing 0.05 g/l of butylated hydroxytoluene and 2 ml of hexane. The supernatant (20 µl) was injected into an HPLC column (LiChrospher 100 NH2 250 × 4 mm) and fluorescence was measured with an excitation wavelength of 295 nm and an emission wavelength of 327 nm. Intra-assay CV ~4.5%.
Plasma 8-iso-PGF 2 concentration.
The concentration of the F 2 -isoprostane 8-isoprostaglandin F 2 (8-iso-PGF 2 ) was determined by a radioimmunoassay (RIA) using an antibody raised in rabbits by immunization with 8-iso-PGF 2 coupled to bovine serum albumin at the carboxylic acid by the 1,19-carbonyldiimmidazole method (6) . Sensitivity ~23 pmol/l, intra-assay CV ~14.5%. Serum HSP72. Serum HSP72 concentration was measured using an enzyme-linked immunosorbent assay (ELISA) kit (#EKS-700, StressGen Biotechnologies, British Columbia, Canada) as described previously (64) . Sensitivity was ~0.2 ng/ml, with intraassay CV less than 6%.
On each ELISA plate, samples from all three groups and all samples from single subject were represented. The samples were run in duplicates and the mean was calculated.
Values below the detection limit were assigned to the detection limit. (19) . 18S rRNA (Applied Biosystems) was used as endogenous reference. The skeletal muscle expression of HSP72 mRNA and 18S rRNA was determined using multiplex conditions: 50 ng cDNA was mixed with 1× TaqMan universal PCR master mix, 900 nM HSP72 forward primer, 900 nM HSP72 reverse primer, 100 nM of Taqman HSP72 probe, and primer-limited 1× 18S. The final reaction volume of 25 µl was obtained by addition of RNase-free water. All samples were run in duplicates on an ABI PRISM 7700 sequence detector (Applied Biosystems) following standard conditions using 40 cycles.
The HSP72 mRNA expression was quantified using the comparative critical threshold (C T ) method and fold changes from resting conditions were calculated using the 2 -CT method (42) .
Skeletal muscle HSP72 protein expression. Relative HSP72 content was determined using semi-quantitative western blotting technique: The frozen muscle samples were homogenized in ice-cold homogenization buffer (8 µl/mg tissue) containing 50 mM HEPES (#54461, Sigma), 150 mM NaCl (#106404, Merck), 100 mM NaF (#S6521, Sigma), 10 mM sodium pyrophosphate (#S9515, Sigma), 5 mM EDTA (#E4884, Sigma), 0.5% Triton X-100 (#108603, Merck), 2 µg/ml leupeptin (#L2023, Sigma), 2 µg/ml aprotinin (#A1153, Sigma), 100 µg/ml PMSF (#P7626, Sigma), 10 µg/ml pepstatin A (#P4265, Sigma), and pervanadate 1 mM. The latter obtained by adding 30% H 2 O 2 to dissolved sodium orthovanadate (#S6508, Sigma) for 15 min at room temperature. The buffer was adjusted to pH 7.5 prior to use. After homogenization, the samples were centrifuged at 1000 g for 10 min at 4 °C and the supernatant was stored at -20 °C until further analysis. The total protein concentration of the supernatant was determined with the Bradford technique (9) using a pre-developed protein staining assay (#500-0006, Bio-Rad Laboratories, Hercules, California). Biotechnologies), we estimated the detection limit of the HSP72 western blotting to ~1 ng/lane and the intra-assay CV to less than 10%.
Statistical analysis. For all data, the distribution of the data was compared with the normal distribution before further statistical analysis. Skeletal muscle HSP72 mRNA expression and serum [HSP70] were normally distributed after log-transformation. Regarding age, BMI, and P max , the data were tested for differences between groups using unpaired t-tests. For plasma vitamins and serum HSP72
concentrations, repeated measure analysis was performed using a mixed model assuming a first-order autoregressive covariance structure among the repeated measurements.
Significant changes from rest (0 h) were analyzed by Bonferroni-adjusted paired t-tests..
For results expressed as fold changes from rest (plasma 8-iso-PGF 2 , skeletal muscle HSP72 mRNA and protein), overall differences between groups were tested by comparing the area under the curve (AUC) with unpaired t-tests, followed by Bonferroni-adjusted unpaired t-tests at individual timepoints, while changes from rest within each group were tested by Bonferroni-adjusted one-sample t-tests.
The statistical analysis was performed using SAS statistical software (release 8.02, SAS Institute Inc., Cary, North Carolina, USA). Throughout the statistical analysis, a P-value lower than 0.05 was set as level of significance.
RESULTS
The three groups were comparable with regard to age, height, BMI and maximal power output (Table 1) .
Plasma vitamin C and E concentrations. On day 28 of the supplementation, the three groups were markedly different with regard to plasma vitamin levels: At rest, plasma
[ascorbic acid] (Fig. 1A) (Fig. 1B) was approximately 30% higher in both CE and CE (overall effect of treatment P<0.05 in
both CE and CE ). No significant changes in plasma [ -tocopherol] from 0 h to 3 h and 6
h were observed in any of the groups. In CE , plasma [ -tocopherol] (Fig. 1C) was at all time points 3-fold lower than in CONTROL (overall effect of treatment P<0.001) and even decreased over time (overall effect of time P<0.01). In contrast, plasma [ -tocopherol] in CE at all time points was more than 5-fold higher than in CONTROL (overall effect of treatment P<0.001) with a borderline-significant increase over time (overall effect of time
P=0.054). In CONTROL, plasma [ -tocopherol] did not change in response to exercise.
Plasma lipid peroxidation. The plasma 8-iso-PGF 2 level (Fig. 1D) increased from 0 h to 3 h in all groups (P<0.05 in all groups), but compared to CONTROL the increase was markedly attenuated (P<0.05) in CE , while the plasma 8-iso-PGF 2 level in CE increased at least just as much as in CONTROL. At 6 h, the plasma 8-iso-PGF 2 levels had returned to baseline values in all groups.
Skeletal muscle expression of HSP72. In CONTROL, HSP72 mRNA expression ( Fig. 2A) in the contracting skeletal muscle increased approximately 2.5-fold (P<0.05) from rest (0 h) to immediately post exercise (3 h), and returned to baseline level after the 3-hour recovery period (6 h). In CE , no significant change in HSP72 mRNA expression from rest to 3 h or 6 h was detected. Also, there was no difference between CE and CONTROL at any time point. In contrast, the HSP72 mRNA expression at 3 h and 6 h was markedly lower (P<0.05 at both time points) in CE compared to CONTROL. Of note, a borderlinesignificant decrease (Bonferroni-adjusted P=0.082) of HSP72 mRNA expression from 0 h to 6 h was observed in CE .
Skeletal muscle HSP72 protein ( Fig. 2B and 2C ) did not change significantly in response to the 3-hour bout of knee-extensor exercise in any of the three groups, though a trend for an increase was present in CONTROL (P=0.066). However, the skeletal muscle HSP72
protein expression was lower (P<0.05) in CE relative to CONTROL immediately after exercise (3 h).
A scatter-plot of the skeletal muscle HSP72 mRNA and protein expression at the end of the exercise (Fig. 2D) Circulating levels of HSP72. The basal (0 h) serum HSP72 concentration (Fig. 2E) was not different between groups. In response to exercise, increased serum HSP72 levels were observed in CE and CONTROL (overall effect of time P<0.05 in both groups), though post hoc analysis only detected a significant increase (P<0.05) from 0 h to 3 h in CONTROL.
However, no change in serum HSP72 in response to acute exercise was observed CE .
In fact, 5 out of 7 subjects in CE had serum HSP72 concentrations below the detection limit of the assay at all time points.
The serum HSP72 concentration at the end of the exercise (3 h) correlated negatively with the plasma -tocopherol level (Fig. 2F) . Within each group, the highest serum HSP72
concentration at 3 h was associated with the lowest plasma -tocopherol level, and vice versa, though the correlation was significant only when comparing all subjects irrespective of group. of the both catecholamines.
Plasma glucose. No difference in plasma [glucose] (

DISCUSSION
The main finding of the present study was that oral supplementation with vitamins C and E inhibited the exercise-induced increase of HSP72 in contracting skeletal muscle and in the circulation, but only when the supplementation included the vitamin E isoformtocopherol.
Using the dynamic knee-extensor exercise model associated with no or minimal muscle damage (21), we observed a 2.5-fold increase in the skeletal muscle HSP72 mRNA in the placebo-treated group. In all three groups, no significant change of the skeletal muscle HSP72 protein level was observed, but a borderline increase was present in the control group (P=0.066). Due to the positive correlation between skeletal muscle HSP72 mRNA and protein post exercise (Fig. 2C) , it is very likely that a significant increase in skeletal muscle HSP72 protein would have been detected in the control group, if the interindividual variation had been smaller or more subjects had been included. Accordingly, a type 2 error regarding the skeletal muscle HSP72 protein data should not be excluded.
Another limitation is the possible effect of the supplementation on the basal expression of HSP72 mRNA and protein in skeletal muscle, since the aim was to determine differences in inducibility. Though alterations in the basal expression of HSP72 mRNA and protein in skeletal muscle in response to the supplementation may have occurred, the basal levels of serum HSP72 were not different between groups (Fig. 2E) . Importantly, the present results regarding the exercise-induced skeletal muscle HSP72 expression in the placebo-treated group are very similar to previous studies investigating the effect of running for 30 min (58) or bicycling for ~3 hours (19) . A previous study performed in our laboratory (21) using a lower workload (40% of P max ) only showed a significant increase in skeletal muscle HSP72 mRNA and protein after knee-extensor exercise in the leg, which had performed glycogendepleting exercise the day before the experiment. Otherwise, increased HSP72 protein levels in skeletal muscle have been reported in studies using eccentric exercise (61) or prolonged running (43; 64) . In the present study, a 4-fold increase of HSP72 in the circulation immediately after exercise was observed. An up to 10-fold increase of serum HSP72 has been reported in two studies using 60 min of running (64) or 120 min of bicycling as exercise (20) . Of note, the latter study also showed that the circulating HSP72
comes from the hepatosplanchnic region and not from the contracting muscle, at least in response to concentric exercise. Altogether, the previous studies and the present results indicate that exercise generally increases skeletal muscle mRNA, while HSP72 protein levels only increase markedly after more intense exercise or in response to exercise with an eccentric component associated with muscle damage.
While we found no effect of supplementation with ascorbic acid and -tocopherol on HSP72 in response to exercise, the combination of ascorbic acid, -tocopherol, andtocopherol clearly inhibited the exercise-induced increase of HSP72 mRNA and protein, as well as HSP72 in the circulation. Importantly, it is the first time that the effect of antioxidants on circulating HSP72 has been reported. In the study by Khassaf et al (35) , vitamin C supplementation alone attenuated the exercise-induced increase of skeletal muscle HSP72, while basal HSP72 expression increased, but whether this could be explained by an antioxidative effect of vitamin C was not established. Of note, supplementation with antioxidants may in some instances increase rather than decrease oxidative stress (12) . Here, the exercise-induced lipid peroxidation was attenuated in the CE group, indicating that the employed supplementation attenuated oxidative stress, However, only the -tocopherol-containing supplementation appeared to inhibit the exercise-induced increase of HSP72 within the contracting muscle as well as the release of HSP72 from the hepatosplanchnic region.
Two explanations for the differential effect of the two combinations of antioxidants should be considered: either the depletion of -tocopherol when providing supplementation withtocopherol partly counteracts the overall antioxidant effect indicated by decreased lipid peroxidation. Alternatively, the effect of surplus -tocopherol may specifically inhibit HSP72 in response to exercise. Though not conclusive, the association between high plasmatocopherol levels and low serum HSP72 levels (Fig. 2F) supports the latter point of view. In vitro, a combination of -, -and -tocopherol is a more efficient inhibitor of lipid peroxidation in erythrocytes when compared to -tocopherol alone (40) . The combination containing -tocopherol did, however, not appear to be a more efficient antioxidant than the combination without -tocopherol, at least when using the F 2 -isoprostane 8-iso-PGF 2 as marker of lipid peroxidation. Interestingly, -tocopherol -but not -tocopherol -is a scavenger of peroxynitrite (13; 66) , which at least in vitro is a highly potent stimulus of HSP synthesis in monocytes (1) . Moreover, recent data suggest that -tocopherol has important anti-inflammatory and anti-neoplastic properties not related to the antioxidative capacity (24; 28; 31; 33) . In the present study, concentric exercise was employed in order to avoid muscle damage associated with inflammation. Of note, no increase of creatine kinase from rest to 3 hours post exercise was observed in any of the groups (not shown).
Accordingly, an anti-inflammatory effect of -tocopherol is not likely to be involved in the modulation of HSP72 in response to non-damaging exercise. However, specific data demonstrating the differences between -and -tocopherol in vivo are yet insufficient.
Importantly, though oxidative stress is one important stimulus for increased HSP synthesis (63) , several other exercise-related stressors of the cellular homeostasis have been shown to induce HSPs either in vivo or in vitro: elevated temperature (48), decreased glucose availability (7), increased intracellular calcium levels (65), increased adrenergic stimulation (54), ischemia (44) , and hypoxia (25) . In the present study, we did not observe changes in plasma glucose or catecholamines that indirectly could explain the effect of -tocopherol.
Of note, the exercise-induced increase of plasma cortisol observed in the placebo-treated group was blunted in both of the antioxidant-treated groups, which is in accordance with previous studies (51; 55). However, since the effect of either antioxidant combination on plasma cortisol was similar, neither cortisol does appear to be an important link between antioxidants with -tocopherol and the effect on HSP72. Furthermore, since the workload was comparable between groups, it is not likely that perfusion, intramuscular temperature, or intracellular calcium would differ between groups to a point, which could explain the effect of supplementation containing -tocopherol on HSP72. Accordingly, it is likely that the effect of ascorbic acid, -tocopherol and -tocopherol on HSP72 was mediated through an effect on ROS and RNS generated in response to exercise. Of note, the positive correlation between skeletal muscle HSP72 mRNA and protein in all three groups
indicates that the effect of the -tocopherol-containing supplementation on HSP72 is exerted at the level of gene transcription, though the exact mechanism by whichtocopherol may inhibit HSP72 in vivo warrants further research. Moreover, the effect oftocopherol alone was not tested in the present study, since -tocopherol was employed in order to counteract the effect of -tocopherol on plasma vitamin E concentrations.
However, the present findings indicate that future studies using supplementation with purified -tocopherol -with or without ascorbic acid -may provide interesting data.
Since extracellular HSP72 may mediate an inflammatory response via binding to the CD14-receptor located on monocytes (4), it could be speculated that antioxidants containing -tocopherol may be used as an anti-inflammatory compound: in vitro, -tocopherol is a more potent inhibitor of cyclooxygenase activity in macrophages when compared with -tocopherol (33) . Also, low plasma concentrations of -tocopherol have been associated with increased cardiovascular mortality (46) as well as increased risk of development of prostate cancer (27) . In this context, supplementation with -tocopherol may be relevant. On the other hand, a suppression of exercise-induced increase of HSP72 might be disadvantageous: while regular exercise training increases the basal skeletal muscle HSP72 content (41), low skeletal muscle HSP72 is associated with insulinresistance (37) and type 2 diabetes (10). Regardless, our results support the opinion that the two vitamin E isoforms, -tocopherol and -tocopherol, have important different qualities, which should be considered in future studies (32) .
In summary, our results show that 28 days of oral supplementation with ascorbic acid, -tocopherol, and -tocopherol inhibits the increase of HSP72 -in skeletal muscle and in the circulation -in response to acute exercise.
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